Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Drug Combinations »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Carriers (pharmacology) < Drug Combinations < Drug Combinations (adverse effects)  Facettes :

List of bibliographic references indexed by Drug Combinations

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000265 (2016) Priti Gros [Canada] ; Victoria P. Mery [Chili] ; Anne-Louise Lafontaine [Canada] ; Ann Robinson [Canada] ; Andrea Benedetti [Canada] ; R John Kimoff [Canada] ; Marta Kaminska [Canada]Obstructive sleep apnea in Parkinson's disease patients: effect of Sinemet CR taken at bedtime.
000464 (2016) Lucia Ricciardi [Royaume-Uni] ; Francesco Bove [Italie] ; Kristy J. Espay [États-Unis] ; Francesco Lena [Italie] ; Nicola Modugno [Italie] ; Yu-Yan Poon [Canada] ; Robert Krikorian [États-Unis] ; Alberto J. Espay [États-Unis] ; Alfonso Fasano [Canada]24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.
000568 (2015) Constant V. M. Verschuur [Pays-Bas] ; S. R. Suwijn [Pays-Bas] ; B. Post [Pays-Bas] ; M. Dijkgraaf [Pays-Bas] ; B. R. Bloem [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; T. Van Laar [Pays-Bas] ; G. Tissingh [Pays-Bas] ; G. Deuschl [Allemagne] ; A. E. Lang [Canada] ; R. J. De Haan [Pays-Bas] ; R. M. A. De Bie [Pays-Bas]Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study
000674 (2015) Anthony E. Lang ; Ramon L. Rodriguez ; James T. Boyd ; Sylvain Chouinard ; Cindy Zadikoff ; Alberto J. Espay ; John T. Slevin ; Hubert H. Fernandez ; Mark F. Lew ; David A. Stein ; Per Odin ; Victor S. C. Fung ; Fabian Klostermann ; Alfonso Fasano ; Peter V. Draganov ; Nathan Schmulewitz ; Weining Z. Robieson ; Susan Eaton ; Krai Chatamra ; Janet A. Benesh ; Jordan DubowIntegrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
000676 (2015) Alfonso Fasano [Canada] ; Louis W C. Liu ; Yu-Yan Poon ; Antony E. LangInitiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model.
000752 (2015) Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie]Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
000788 (2015) Alison C. Simioni ; Alain Dagher ; Lesley K. FellowsCompensatory striatal–cerebellar connectivity in mild–moderate Parkinson's disease
000951 (2014) Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Robert A. Hauser [États-Unis] ; Stanley Fahn [États-Unis] ; Joseph Jankovic [États-Unis] ; Emmanuelle Pourcher [Canada] ; Ann Hsu [États-Unis] ; Martin O'Connell [États-Unis] ; Sherron Kell [États-Unis] ; Suneel Gupta [États-Unis]Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.
001680 (2011) Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada]Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study
002415 (2008) Jon B. Doan [Canada] ; Kyle G. Melvin [Canada] ; Ian Q. Whishaw [Canada] ; Oksana Suchowersky [Canada]Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms
002703 (2006) R B Postuma [Canada] ; A J Espay ; C. Zadikoff ; O. Suchowersky ; W R W. Martin ; A-L Lafontaine ; R. Ranawaya ; R. Camicioli ; A E LangVitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.
002979 (2005) Mohammed Khysar Pasha [Canada] ; Rajendra K. Sharma ; Alexander H. RajputIncreased myocardial N-myristoyltransferase activity in rotenone model of Parkinsonism.
002C06 (2004) Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada]Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations
002F27 (2003) Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada]Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair
003A68 (1997) H. Shinotoh [Canada] ; F J Vingerhoets ; C S Lee ; R J Uitti ; M. Schulzer ; D B Calne ; J. TsuiLamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
004041 (1995) Angela Lang [Canada]Hemiatrophy, juvenile‐onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult‐onset hemiparkinsonism: The spectrum of hemiparkinsonism‐hemiatrophy syndrome
004437 (1993) P. J. Bedard ; B. Gomez-Mancilla ; P. Blanchette ; C. Gagnon [Canada] ; P. Falardeau [Canada] ; T. Dipaolo [Canada]Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys
004985 (1990) N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. KaraSinemet-ferrous sulphate interaction in patients with Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Drug Combinations" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Drug Combinations" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Combinations
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022